Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
EVHthis companyEvolent Health, Inc.	$4.65	-0.79×	1.1×	0.24×	-3.58×	-2363.6%	15.1%	-0.2%	-28.5%	-128.7%	-0.3%	1.0%	2.38×	-2.32×	-0.08×	1.31×	2.4%	5	-0.38	2	C+
AMNAMN Healthcare Services, Inc.	$36.96	-6.35×	0.95×	0.22×	13.61×	105.8%	28.3%	1.2%	-3.5%	-14.9%	2.1%	38.5%	1.25×	7.61×	0.73×	0.94×	0.0%	8	3.22	4	A-
AVBPArriVent BioPharma, Inc.	$14.54	-4.66×	2.52×	0×	-4.38×	-92.2%	0.0%	0.0%	0.0%	-54.1%	-57.8%	-20.8%	0×	0.27×	0×	12.83×	0.0%	2	12.15	2	C+
BFLYButterfly Network, Inc.	$6.65	-12.26×	4.79×	9.62×	-12.01×	-165.5%	46.9%	-88.5%	-79.0%	-39.3%	-36.9%	-1.7%	0.1×	1.93×	-58×	3.83×	0.0%	3	5.72	1	C-
HSTMHealthStream, Inc.	$29.05	37.82×	1.96×	2.28×	10.06×	87.1%	64.7%	6.7%	6.0%	5.2%	4.0%	8.6%	0.04×	-0.32×	0×	0.96×	0.5%	7	5.07	4	A-
KURAKura Oncology, Inc.	$7.56	-3.27×	5.23×	13.5×	-2.84×	72.0%	99.9%	-449.9%	-412.9%	-160.0%	-48.8%	-7.8%	0.12×	0.47×	-200.81×	6.06×	0.0%	3	-2.79	2	C
Peer median	—	-4.66×	2.52×	2.28×	-2.84×	72.0%	46.9%	0.0%	-3.5%	-39.3%	-36.9%	-1.7%	0.1×	0.47×	0×	3.83×	0.0%	3	5.07	2	—